Hematology Masterclass vs Multiple Myeloma [MM] Usage & Stats

Name-tag, program, speakers and all what you need to attend 3rd Hematology Masterclass. [:mav: 1.0.3]
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Myeloma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Multiple Myeloma @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Multiple Myeloma content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

Hematology Masterclass vs. Multiple Myeloma [MM] ranking comparison

Compare Hematology Masterclass ranking trend in the past 28 days vs. Multiple Myeloma [MM]

Rank

No Data Available

Hematology Masterclass vs. Multiple Myeloma [MM] ranking by country comparison

Compare Hematology Masterclass ranking trend in the past 28 days vs. Multiple Myeloma [MM]

No Data to Display

Compare to any site with our free trial

Get started
Hematology Masterclass VS.
Multiple Myeloma [MM]

December 14, 2024